XML 103 R26.htm IDEA: XBRL DOCUMENT
v3.25.3

Financial Instruments (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Investments, All Other Investments [Abstract] |
Schedule of Cash and Marketable Securities by Significant Investment Category | The following tables show the Company’s cash, cash equivalents, restricted cash, and marketable securities by significant investment category as of: Schedule of Cash and Marketable Securities by Significant Investment Category
|  | September 30, 2025 |
|  | cost |  |  | Unrealized Gain/(Loss) |  |  | Fair Value |  |  | Cash and Cash Equivalents |  |  | Marketable Securities |  |  | Investments |
Cash |  | $ | 5,785,000 |  |  | $ | - |  |  | $ | 5,785,000 |  |  | $ | 5,785,000 |  |  | $ | - |  |  | $ | - |
Restricted Cash |  |  | 100,000 |  |  |  | - |  |  |  | 100,000 |  |  |  | 100,000 |  |  |  | - |  |  |  | - |
Level 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money Market Funds |  |  | 1,234,000 |  |  |  | - |  |  |  | 1,234,000 |  |  |  | 1,234,000 |  |  |  | - |  |  |  | - |
Marketable Securities |  |  | 25,619,000 |  |  |  | (15,797,000 | ) |  | $ | 9,822,000 |  |  |  | - |  |  |  | 9,822,000 |  |  |  | - |
Total |  | $ | 32,738,000 |  |  | $ | (15,797,000 | ) |  | $ | 16,941,000 |  |  | $ | 7,119,000 |  |  | $ | 9,822,000 |  |  | $ | - |
|  | December 31, 2024 |
|  | Adjusted Cost |  |  | Unrealized Gain/(Loss) |  |  | Fair Value |  |  | Cash and Cash Equivalents |  |  | Marketable Securities |  |  | Investments |
Cash |  | $ | 11,369,000 |  |  | $ | - |  |  | $ | 11,369,000 |  |  | $ | 11,369,000 |  |  | $ | - |  |  | $ | - |
Level 1 |  |  |  |  |  |  |  |  |  | $ | - |  |  |  |  |  |  |  |  |  |  |  |  |
Money Market Funds |  | $ | 62,000 |  |  |  | - |  |  | $ | 62,000 |  |  |  | 62,000 |  |  |  | - |  |  |  | - |
Marketable Securities |  | $ | 25,933,000 |  |  |  | (16,722,000 | ) |  | $ | 9,211,000 |  |  |  | - |  |  |  | 9,211,000 |  |  |  | - |
Total |  | $ | 37,364,000 |  |  | $ | (16,722,000 | ) |  | $ | 20,642,000 |  |  | $ | 11,431,000 |  |  | $ | 9,211,000 |  |  | $ | - |

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration